Scipher Medicine snaps up $82m
Scipher Medicine, a precision immunology company, has secured $82 million in Series C financing.
Scipher Medicine, a precision immunology company, has secured $82 million in Series C financing.
Copyright PEI Media
Not for publication, email or dissemination